Summary
I Financial Ventures Group LLC, listed as holding roughly 10% of Nano Nuclear Energy Inc (NASDAQ: NNE), executed a series of common-stock sales on January 28 and 29, 2026, that together amounted to $16.78 million. The transactions were completed in multiple tranches at prices ranging from $30.7623 to $35.25 per share. Those sales took place against a backdrop of pronounced share-price volatility: NNE traded most recently at $29.40, down from a prior close of $32.11. InvestingPro data cited a 15.36% decline for the stock over the most recent week while flagging the company as appearing slightly undervalued on Fair Value models.
Details of the January 28 transactions
On January 28, I Financial Ventures reported selling a total of 381,664 shares. The filing lists multiple tranches and weighted-average prices as follows: 179,965 shares sold at a weighted average price of $33.8268; 196,474 shares sold at a weighted average price of $34.4232; an additional 2,222 shares sold at $35.25; 184,403 shares sold at a weighted average price of $33.8268; 201,320 shares sold at a weighted average price of $34.4232; and another tranche of 2,277 shares sold at $35.25.
Details of the January 29 transactions
On January 29, the entity sold a total of 110,339 shares. Tranches reported for that day include 19,584 shares sold at a weighted average price of $30.7623; 87,680 shares sold at a weighted average price of $31.8070; 10,975 shares sold at a weighted average price of $32.8367; and 3,100 shares sold at a weighted average price of $33.7406.
Option exercises and net position
Alongside the public sales, I Financial Ventures acquired shares through the exercise of stock options at an exercise price of $1.50 per share. The filing indicates that on January 28 a total of 378,661 shares were acquired via option exercise. On January 29, a total of 121,339 shares were acquired, corresponding to the component lots of 19,584 shares, 87,680 shares, 10,975 shares and 3,100 shares listed in the filing.
These buy and sell activities were carried out under a Rule 10b5-1 trading plan that I Financial Ventures adopted in September 2025. After the January transactions, the firm directly owns 8,724,000 shares of Nano Nuclear Energy Inc, representing a substantial stake in the company.
Company profile points cited in the filing
The filing and accompanying notes describe Nano Nuclear as a company with a market capitalization of $1.62 billion. The company is reported to hold more cash than debt on its balance sheet and is scheduled to release earnings on February 12. InvestingPro is referenced as identifying 11 additional key insights about NNE and offering a Pro Research Report covering detailed financial health metrics and analysis for more than 1,400 U.S. equities.
Corporate developments and analyst activity
Separately from the insider trading report, Nano Nuclear announced several corporate moves. The company named Michael Montecalvo as its new Licensing Director; the filing notes his more than 30 years of experience in the nuclear industry. Nano Nuclear also issued a Request for Information seeking partners for its LOKI microreactor program aimed at space applications, and it signed a Memorandum of Understanding with South Korea's DS Dansuk Co., Ltd. to collaborate on micro modular reactor systems in South Korea.
On the coverage front, Texas Capital Securities initiated coverage of Nano Nuclear Energy with a Buy rating, specifically pointing to the company's KRONOS MMR reactor and citing its efficiency and safety characteristics. The filing and related commentary additionally note that nuclear energy stocks, including Nano Nuclear, saw increased interest following supportive remarks from U.S. President Donald Trump at the World Economic Forum in Davos.
Context and takeaways
The transaction filing paints a picture of coordinated sales and option exercises within a Rule 10b5-1 plan, resulting in significant cash proceeds while leaving I Financial Ventures with a large direct holding. The company's simultaneous operational updates, external analyst coverage, and macro-level commentary supporting the nuclear sector are detailed in the filings and announcements summarized above. No further projections or conclusions are made in the filing; the company remains on the calendar to report quarterly results on February 12.
Note: The information in this article reflects the contents of the reported filings and company announcements and summarizes those disclosures without adding new facts.